Evidence map›Paper›PMID 38733993›Full record

ArticleCell stem cell2024

Transcription factor dynamics, oscillation, and functions in human enteroendocrine cell differentiation.

Pratik N P Singh, Wei Gu, Shariq Madha, Allen W Lynch, Paloma Cejas, Ruiyang He, Swarnabh Bhattacharya, Miguel Muñoz Gomez, Matthew G Oser, Myles Brown and 4 more

Abstract read
In one paragraph

Article in Cell stem cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The transcription factor FOXQ1 in cancer.Cancer metastasis reviews · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Pratik N P SinghDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Wei GuDivision of Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Shariq MadhaDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Allen W LynchCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Paloma CejasCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Ruiyang HeCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Swarnabh BhattacharyaDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Miguel Muñoz GomezCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Matthew G OserDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Departments of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Myles BrownDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Departments of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Henry W LongCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Clifford A MeyerCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Qiao ZhouDivision of Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: jqz4001@med.cornell.edu.
Ramesh A ShivdasaniDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Departments of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA. Electronic address: ramesh_shivdasani@dfci.harvard.edu.

Funding

STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Scott B Snapper · 1986 to 2026
$32.4M
Project 3 - INSM1, A Candidate Therapeutic Target in High-Grade Neuroendocrine CarcinomasP01CA295524 · NCI · DANA-FARBER CANCER INST · PI James A. DeCaprio · 2025 to 2026
$7.5M
Transcriptional control and enhancer recruitment in mouse and human intestinal secretory differentiationR01DK082889 · NIDDK · DANA-FARBER CANCER INST · PI Ramesh A Shivdasani · 2010 to 2026
$5.2M
NCI NIH HHS P01 CA295524NIDDK NIH HHS P30 DK034854NIDDK NIH HHS R01 DK082889
6 · The paper itself

Abstract

Enteroendocrine cells (EECs) secrete serotonin (enterochromaffin [EC] cells) or specific peptide hormones (non-EC cells) that serve vital metabolic functions. The basis for terminal EEC diversity remains obscure. By forcing activity of the transcription factor (TF) NEUROG3 in 2D cultures of human intestinal stem cells, we replicated physiologic EEC differentiation and examined transcriptional and cis-regulatory dynamics that culminate in discrete cell types. Abundant EEC precursors expressed stage-specific genes and TFs. Before expressing pre-terminal NEUROD1, post-mitotic precursors oscillated between transcriptionally distinct ASCL1

Indexed as

Basic Helix-Loop-Helix ProteinsCell DifferentiationEnteroendocrine CellsTranscription FactorsCell LineageHumansNerve Tissue ProteinsASCL1 protein, humanBasic Helix-Loop-Helix ProteinsNerve Tissue ProteinsNEUROD1 protein, humanNEUROG3 protein, humanTranscription Factorschromatin dynamicsdetermination of terminal cell fateshormone producing cellshuman enteroendocrine cellsintestinal stem cellstranscription factor oscillation

Identifiers

PMID38733993
PMCPMC12005834

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.